MassBio Member News
Have news you'd like to share with the wider biotechnology community? Send your press release, announcements and other news to communications@massbio.org.
Showing news: 381–390 of 575
SEMPRUS BIOSCIENCES RAISES ADDITIONAL $18 MILLION
December 13, 2010 —
Series B Financing to Support First Product Regulatory Clearance and Clinical Validation
Semprus BioSciences, a biomedical company developing products designed to address the 56,000 annual deaths and $11.2 billion in infection- and…
Read More
Attorney Walter J. Sullivan, Jr. Joins Preti Flaherty's Boston Office
December 8, 2010 —
Preti Flaherty announces that Walter J. Sullivan, Jr. has joined the firm’s Boston office. Sullivan practices of counsel with Preti Flaherty’s Regulatory and Government Services and Labor and Employment Groups. He works with members of Preti…
Read More
Aushon BioSystems and LightArray Partner to Offer Protein Biomarker
December 6, 2010 —
Partnership to address increasing demand for protein biomarker testing in pharmaceutical research and development in the Chinese market
BEIJING, China., (November 30, 2010) – Aushon BioSystems, Inc., a leading provider of multiplex…
Read More
Genstruct, Inc. Changes Name to Selventa as Company Launches Re-branding Effort
November 30, 2010 —
CAMBRIDGE, Mass. – November 30, 2010 – SelventaTM, which evolved from Genstruct®, Inc. today announced that it has changed its name and launched a re-branded website as part of an initiative to provide innovative solutions for its client partners.…
Read More
Aushon Introduces New Chief Scientific Officer
November 23, 2010 —
Aushon BioSystems, Inc., a leading provider of advanced microarray products and laboratory services for biomarker discovery, development and analysis, announces that Sven Beushausen, Ph.D., has been appointed to the position of Chief Scientific…
Read More
November 23, 2010 —
FDA Lifts Clinical Hold; Company to Commence a Phase I/II Clinical Trial at Multiple CentersAdvanced Cell Technology, Inc. (“ACT”; OTCBB:ACTC) announced today that the US Food and Drug Administration (FDA) has cleared the Company’s…
Read More
Sistemic Launch SistemTOX™ (v1) First microRNA-Based Toxicity Screening Service
November 19, 2010 —
Unveiling of new service is set to significantly reduce cost of drug development
Glasgow, Scotland, November 15th, 2010 – Sistemic Ltd., the recent winners of the coveted Most Promising Life Science Company by Nexxus, today announced the launch…
Read More
BRM/Biomere Announces the Appointment of a Senior Vice President of Science and Business Development
November 19, 2010 —
Biomedical Research Models Inc./Biomere, a privately held preclinical contract research organization (CRO) which specializes in life-threatening diseases such as autoimmune, multiple sclerosis, diabetes and virology, announced today the appointment of…
Read More
November 18, 2010 —
Anthony J. Coyle, Ph.D. Will Head the Network that Aims to Accelerate and Transform Drug Discovery and Development
NEW YORK, N.Y., November 16 - Pfizer Inc. today announced the establishment of the Global Centers for Therapeutic Innovation,…
Read More
Lancaster Laboratories’ launches new mycoplasma USP <63> assay; harmonizes with EP Guidelines
November 17, 2010 —
Lancaster Laboratories, a global leader in biological safety testing, has introduced a new cGMP compliant mycoplasma assay, harmonizing both United States Pharmacopeia (USP) Chapter <63> monograph and European Pharmacopoeia Chapter…
Read More
Membership Deliverables
MassBio Membership gives you:
Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members.
Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.
MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.
Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.
Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.
Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!
Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.